Elite members get real-time data, technical charting, alerts, and no ads - starting at $24.96/mo.
Try Elite for Free
Last Close
507.48
Nov 05 • 3:59 PM ET Dollar change-3.22 Percentage change(-0.63%)
Aftermarket Close
507.48
Aftermarket • 5:23 PM ET Dollar change0.00 Percentage change(0.00%)
Nov 04, 4:30 AMDemocratic congressional sweep lifts HCA 4% premarket on Medicaid and ACA relief hopes
Index
S&P 500
Market Cap
106.01B
Enterprise Value
160.89B
Income
6.78B
Sales
78.70B
Book/sh
-38.30
Cash/sh
4.88
Employees
320000
IPO
Mar 10, 2011
P/E
16.81
Forward P/E
16.19
PEG
2.19
P/S
1.35
P/B
-
P/C
104.03
P/FCF
17.75
EV/EBITDA
10.19
EV/Sales
2.04
Quick Ratio
0.74
Current Ratio
0.82
Debt/Eq
-
LT Debt/Eq
-
Option/Short
Yes / Yes
EPS (ttm)
30.18
EPS next Y
31.34
EPS next Q
8.18
EPS this Y
6.71%
EPS next Y
4.10%
EPS next 5Y
7.39%
EPS past 3/5Y
13.94% 20.99%
Sales past 3/5Y
7.87% 7.97%
EPS Y/Y TTM
16.59%
Sales Y/Y TTM
5.82%
EPS Q/Q
4.50%
Sales Q/Q
3.59%
Insider Own
33.18%
Insider Trans
0.00%
Inst Own
64.97%
Inst Trans
-1.75%
ROA
11.00%
ROE
-
ROIC
18.69%
Gross Margin
15.31%
Oper. Margin
15.31%
Profit Margin
8.61%
SMA20
8.40%
SMA50
14.79%
SMA200
14.11%
Trades
Shs Outstand
210.88M
Shs Float
139.59M
52W High
556.52 -8.81%
52W Low
353.99 43.36%
Volatility
3.23% 3.27%
ATR (14)
17.43
RSI (14)
68.55
Beta
1.10
Rel Volume
1.23
Avg Volume
1.35M
Volume
1,655,726
Perf Week
6.15%
Perf Month
15.55%
Perf Quarter
22.77%
Perf Half Y
18.29%
Perf YTD
8.70%
Perf Year
7.24%
Perf 3Y
119.84%
Perf 5Y
104.41%
Perf 10Y
573.68%
Prev Close
510.70
Price
507.48
Change %
-0.63%
Consensus
Buy
Avg. Price Target
$480.33
Implied Upside
-5.3%
Analysts13incl. previous ratings
Rating Distribution4 Buy · 8 Hold · 1 Sell
DateActionAnalystRating ChangePrice Target ChangeImplied Upside
Sep 23, 2026Initiated
BMO logoBBMO Capital Markets
Outperform$495-2.5%
Jul 08, 2026Downgrade
BCS logoBBarclays
Overweight → Equal Weight$427-15.9%
Dec 15, 2025Downgrade
MS logoMMorgan Stanley
Equal-Weight → Underweight$425-16.3%
Oct 14, 2025Resumed
GS logoGGoldman
Buy$470-7.4%
Jul 28, 2025Downgrade
WWolfe Research
Outperform → Peer Perform
Jul 16, 2025Downgrade
BAC logoBBofA Securities
Buy → Neutral$394-22.4%
May 29, 2025Upgrade
WFC logoWWells Fargo
Underweight → Equal Weight$385-24.1%
Apr 15, 2025Downgrade
RRobert W. Baird
Outperform → Neutral$336-33.8%
Dec 17, 2024Resumed
JPM logoJJP Morgan
Neutral$380-25.1%
Nov 25, 2024Downgrade
WFC logoWWells Fargo
Equal Weight → Underweight$400 → $320-36.9%
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Jon M FosterOFFICERNov 04 '26Proposed Sale514.0731,74216,317,603Nov 04 08:27 PM
Michael J SchlosserOfficerNov 04 '26Proposed Sale494.651,200593,583Nov 04 04:28 PM
Marks Mike AEVP and CFOOct 30 '26Option Exercise81.964,585375,7874,585Nov 03 07:41 PM
Schlosser Michael JEVP and Chief Clinical OfficerOct 29 '26Option Exercise82.304,928405,5885,098Nov 02 05:52 PM
Michael S CuffeOfficerOct 29 '26Proposed Sale477.0011,8005,628,600Oct 29 04:18 PM
McAlevey Michael REVP & Chief Legal & Admin Off.Feb 13 '26Option Exercise236.615,0001,183,05013,853Feb 18 07:18 PM
McAlevey Michael REVP & Chief Legal & Admin Off.Feb 18 '26Sale533.371,694903,5378,853Feb 18 07:18 PM
Michael R McAleveyOFFICERFeb 18 '26Proposed Sale533.341,694903,486Feb 18 04:18 PM
Wyatt Christopher F.SVP & ControllerFeb 11 '26Sale505.004,0002,020,00044,379Feb 12 06:55 PM
Berres JenniferSVP & Chief Human Res. OfficerFeb 11 '26Sale514.588,0204,126,95011,993Feb 12 06:36 PM
Jennifer L. BerresOFFICERFeb 11 '26Proposed Sale514.588,0204,126,950Feb 11 04:37 PM
Wyatt Christopher F.SVP & ControllerFeb 05 '26Option Exercise139.0610,6701,483,77051,737Feb 09 06:13 PM
Foster Jon MEVP and COOFeb 05 '26Option Exercise139.0629,3304,078,63029,330Feb 09 06:08 PM
HAZEN SAMUEL NCEOFeb 03 '26Sale501.0442,87721,483,27532,276Feb 05 06:33 PM
Cuffe Michael S.EVP and Chief Clinical OfficerFeb 03 '26Sale498.091,500747,13530,003Feb 05 06:22 PM
MICHAEL S CUFFEOFFICERFeb 03 '26Proposed Sale498.091,500747,135Feb 03 04:36 PM
Samuel N. HazenPresident, Chief Executive OffFeb 03 '26Proposed Sale501.0442,87721,483,274Feb 03 04:33 PM
HAZEN SAMUEL NCEOJan 30 '26Option Exercise81.9684,3606,914,146116,636Feb 02 06:49 PM
HCA Healthcare, Inc. is a health care services company, which engages in operating hospitals, freestanding surgery centers and emergency care facilities, urgent care facilities, walk-in clinics, diagnostic and imaging centers, radiation and oncology therapy centers, comprehensive rehabilitation and physical therapy centers, physician practices, home health, hospice, outpatient physical therapy home and community-based services providers, and various other facilities. The firm operates general and acute care hospitals that offer medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services, and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy. The company was founded by Dr. Thomas F. Frist, Jr in 1968 and is headquartered in Nashville, TN.
CEO & DirectorMr. Samuel N. Hazen
CFO & Executive VPMr. Michael A. Marks
Executive VP & COOMr. Jon Mack Foster
Executive VP and Chief Legal & Administrative OfficerMr. Michael R. McAlevey
M.D.Dr. Michael S. Cuffe M.B.A.